Before you sell to, join or invest in Oncology Institute, Inc.
MentionFox check on Oncology Institute, Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/oncology-institute-inc-form-d-25000001
Check Oncology Institute, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Oncology Institute, Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Oncology Institute, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-08.
Oncology Institute, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 8, 2025. The filing reports $16.44M sold. Its industry group is Hospitals and Physicians. It names Daniel Virnich (Executive Officer, Director), Robert Carter (Executive Officer), Jeremy Castle (Executive Officer) (SEC Form D, April 8, 2025).
Is this your company?
Sell to companies like Oncology Institute, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Oncology Institute, Inc.
Free to see. No signup.
More on the people and the money behind Oncology Institute, Inc., from the filings we hold.
BTIG, LLC received sales compensation on this raise and on 3 other raises we hold, nearest in date first:
Hospitals and Physicians raises filed within 90 days of this one, largest first.
Get an email when Oncology Institute, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Oncology Institute, Inc. raises, hires or launches. No email unless you switch it on.
Watch Oncology Institute, Inc. →Get the full cited report on Oncology Institute, Inc.
What the filing shows about Oncology Institute, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Oncology Institute, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Oncology Institute, Inc.'s address as 18000 Studebaker Rd, Suite 800, Cerritos, CA 90703.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Oncology Institute, Inc. See pricing
Oncology Institute, Inc. is a registered filer with the SEC (CIK 1799191) and has filed since 2025-04-08. 1 filing is on record, the latest on 2025-04-08.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Oncology Institute, Inc.'s Form D of 2025-04-08 names Daniel Virnich, Robert Carter, Jeremy Castle and 8 more as its officers, directors or promoters.
Its new offerings report $16.44M sold across 1 offering, as its own filings state.
Trailing twelve months. 29 filings in Hospitals and Physicians, totalled by week.
Daniel Virnich is named as Executive Officer and Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Robert Carter is named as Executive Officer on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Jeremy Castle is named as Executive Officer on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Yale Podnos is named as Executive Officer on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Richard Barasch is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Brad Hively is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Anne McGeorge is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Karen Johnson is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Mohit Kaushal is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Mark Pacala is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
Gabriel Ling is named as Director on the Form D that Oncology Institute, Inc. filed with the SEC on 8 April 2025, one of 11 people that filing names.
11 people named on the filing — 4 holding an executive role and 7 as directors only.
Named as of the 2025-04-08 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Oncology Institute, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Oncology Institute, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Oncology Institute, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Oncology Institute, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Oncology Institute, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Oncology Institute, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/oncology-institute-inc-form-d-25000001